Nov 12 (Reuters) - Myriad Pharmaceuticals Inc:
* Reports first quarter fy' 2010 financial results
* Q1 research revenue $60,000
* Q1 loss per share $0.44
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Reports first quarter fy' 2010 financial results
* Q1 research revenue $60,000
* Q1 loss per share $0.44
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
